Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

Summary

Open label, randomized, 4-period crossover study with single doses of BMS-986141 given to healthy female subjects of non-childbearing potential and healthy males.

Timeline

Start

2017-01-25

Primary completion

2017-02-07

Completion

2017-02-07

Outcome

Outcome not reported

Stopped (Business): “Business objectives have changed”

Drugs

Indications

No indication recorded.